BR0313230A - Uso de carboxamidas para o tratamento de tinido - Google Patents

Uso de carboxamidas para o tratamento de tinido

Info

Publication number
BR0313230A
BR0313230A BR0313230-7A BR0313230A BR0313230A BR 0313230 A BR0313230 A BR 0313230A BR 0313230 A BR0313230 A BR 0313230A BR 0313230 A BR0313230 A BR 0313230A
Authority
BR
Brazil
Prior art keywords
carboxamides
tinnitus treatment
treatment
tinnitus
relates
Prior art date
Application number
BR0313230-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0218243A external-priority patent/GB0218243D0/en
Priority claimed from GB0218244A external-priority patent/GB0218244D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0313230A publication Critical patent/BR0313230A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BR0313230-7A 2002-08-06 2003-08-05 Uso de carboxamidas para o tratamento de tinido BR0313230A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0218243A GB0218243D0 (en) 2002-08-06 2002-08-06 Organic compounds
GB0218244A GB0218244D0 (en) 2002-08-06 2002-08-06 Organic compounds
PCT/EP2003/008669 WO2004014391A1 (en) 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus

Publications (1)

Publication Number Publication Date
BR0313230A true BR0313230A (pt) 2005-07-12

Family

ID=31716915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313230-7A BR0313230A (pt) 2002-08-06 2003-08-05 Uso de carboxamidas para o tratamento de tinido

Country Status (8)

Country Link
US (1) US7465723B2 (cg-RX-API-DMAC10.html)
EP (1) EP1528927A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005538126A (cg-RX-API-DMAC10.html)
CN (1) CN1674909A (cg-RX-API-DMAC10.html)
AU (1) AU2003266965A1 (cg-RX-API-DMAC10.html)
BR (1) BR0313230A (cg-RX-API-DMAC10.html)
CA (1) CA2494660A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004014391A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
PE20051156A1 (es) * 2004-03-22 2006-02-13 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
EP2380573B1 (en) * 2005-05-06 2015-02-25 Bial-Portela & CA, S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US9410427B2 (en) * 2012-06-05 2016-08-09 United Technologies Corporation Compressor power and torque transmitting hub
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL125244A (en) 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
JP2005538126A (ja) 2005-12-15
WO2004014391A1 (en) 2004-02-19
US20060106009A1 (en) 2006-05-18
WO2004014391B1 (en) 2004-04-15
CA2494660A1 (en) 2004-02-19
EP1528927A1 (en) 2005-05-11
US7465723B2 (en) 2008-12-16
CN1674909A (zh) 2005-09-28
AU2003266965A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MXPA03001789A (es) Composiciones para el cuidado de telas que comprenden silicones cationicos y metodos que emplean las mismas.
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
SE0100901D0 (sv) New composition
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60106954D1 (de) Resorcin-derivate
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ITMI20010957A0 (it) Derivati dell&#39;aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
SI1475379T1 (sl) Uporaba derivatov skopinskega estra za pripravo zdravil
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2157 DE 08/05/2012.